ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

NGEN Nervgen Pharma Corporation

2.04
0.06 (3.03%)
Last Updated: 08:43:50
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End December 30 2023 201820192020202120222023
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Total Assets 3.1M6.77M6.68M17.9M23.88M13.24M
Total Current Assets 2.55M6.26M6.2M17.42M23.15M12.52M
Cash and Equivalents 2.47M4.11M5.6M16.93M22.45M11.66M
Total Non-Current Assets 2.51M5.84M5.92M16.82M13.46M-2.01M
Total Liabilities 583k924k755k1.08M10.41M15.25M
Total Current Liabilities 449k924k755k1.08M10.22M15.14M
Total Non-Current Liabilities 134k000197k105k
Total Equity 2.51M5.84M5.92M16.82M13.46M-2.01M
Common Equity 3.85M15.29M22.95M42.4M57.41M58.93M
Retained Earnings -1.37M-11.14M-22.32M-35.05M-55.77M-78.15M

Your Recent History

Delayed Upgrade Clock